医疗机构在优化院内药品结构、合理调整药品目录的工作中，对待遴选药品进行多维度综合评价对保障临床基本用药的供应与规范使用具有重要意义。国内在药品遴选及评价方法方面的研究相对薄弱，与国外存在较大差距，且目前国内现有的药品遴选评价方法由于评价策略和指标体系存在较大的差异性，给医疗机构的选择带来了困惑。因此，根据国内实际情况，制定符合医疗机构药品准入与调出工作实际的药品遴选评价方法至关重要。通过对国内现有药品遴选评价方法进行分析，并结合自身工作实践，提出构建符合国内医疗机构药品目录动态调整工作实际的药品遴选评价方法的策略建议，为医疗机构规范开展药品遴选评价工作提供参考。

In optimizing the internal drug structure and properly adjusting the drug catalog, it is of significant importance for medical institutions to perform a multidimensional comprehensive evaluation of selected drugs to ensure the supply and proper use of essential drugs in clinical settings. Research on drug selection and evaluation methods within domestic institutions is relatively weak compared to foreign countries, and there is a significant gap. Additionally, the existing drug selection and evaluation methods in domestic institutions have caused confusion due to substantial differences in evaluation strategies and indicator systems. Therefore, it is crucial to develop drug selection and evaluation methods tailored to the actual conditions of drug access and removal in medical institutions based on the domestic situation. This paper analyzes the existing domestic drug selection and evaluation methods and proposes strategic suggestions for developing drug selection and evaluation methods that align with the practical dynamics of drug catalog adjustment in Chinese medical institutions, providing a reference for standardizing drug selection and evaluation work in medical institutions.

R97

广东省医学科学技术研究基金项目（A2023283）；广东省医院药学研究基金项目（2024A17）；深圳市卫生经济学会科研基金项目（202414）